Krebs Biochemicals & Industries P/B Ratio
KREBSBIO • Price-to-Book ratio analysis and book value breakdown
Current P/B Ratio
-0.96
Low Valuation
Very Low - Significant discount to book value, potential distress or value opportunity
Current Valuation Metrics
P/B Ratio
-0.96
Current Price
₹69.56
Book Value/Share
₹-66.36
Exchange
NSE
Book Value Breakdown (2025)
Balance Sheet Components
Total Equity
₹-146 Cr
Share Capital
₹22 Cr
Reserves & Surplus
₹-168 Cr
Outstanding Shares
22,000,000
Book Value per Share
₹-66.36
Valuation Signal
Signal
Undervalued
Sector Context
Sector Average
-0.05
Sector Median
0.74
Sector Rank
#8 of 50
Sector Percentile
16.0%
Key P/B Ratio Insights for Krebs Biochemicals & Industries
- Stock appears undervalued with PB of -0.96, trading below book value
- Trading below book value - potential value opportunity or financial distress signal
- Trading at discount to sector average PB of -0.05
View the current stock price of Krebs Biochemicals & Industries for more insights.
Related Pages for Krebs Biochemicals & Industries
Additional stock information and data for KREBSBIO
Sector P/B Ratio Comparison
Comparing Krebs Biochemicals & Industries with other companies in Healthcare sector
Sector Average
-0.05
Sector Median
0.74
Lowest P/B
-12.71
Highest P/B
1.21
Companies
50
| Company | Symbol | P/B Ratio | Market Cap (₹ Cr) | Valuation |
|---|---|---|---|---|
| Sun Pharma Advanced Rese… | SPARC | -12.71 | ₹4,389 | Low |
| Span Divergent | SDL | -6.32 | ₹19 | Low |
| Oxygenta Pharmaceutical | OXYGENTAPH | -5.54 | ₹203 | Low |
| Satiate Agri | SATAGRI | -3.39 | ₹8 | Low |
| Adline Chem Lab | ADLINE | -3.03 | ₹5 | Low |
| Bharat Immunologicals | BIBCL | -2.47 | ₹95 | Low |
| Parmax Pharma | PARMAX | -2.15 | ₹12 | Low |
| Triochem Products | TRIPR | 0.04 | ₹0 | Low |
| Murae Organisor | MURAE | 0.27 | ₹57 | Low |
| Mangalam Drugs & Organics | MANGALAM | 0.32 | ₹38 | Low |